However, this experimental platform suffers from two significant flaws: first, the PD-L1 antibody can directly affect PD-L1 expressing tumor cells, and second, the addition of an antibody to the culture may result in neutrophil killing of tumor cells via antibody-dependent cellular cytotoxicity (ADCC). This evidence concerns the gene CD274 and neoplasm.